Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
PEG-BCT-100
BIOLOGICAL
2 trials
Sponsors
Bio-Cancer Treatment International Limited
Conditions
Acute Myeloid Leukemia
Melanoma
Prostate Adenocarcinoma
Phase 1
Recombinant Human Arginase 1 (rhArg1) in Patients With Advanced Arginine Auxotrophic Solid Tumors
Completed
NCT02285101
Bio-Cancer Treatment International Limited
Melanoma, Prostate Adenocarcinoma
Start: 2014-11-30
End: 2019-02-28
Updated: 2020-04-24
Phase 2
Efficacy and Safety Study of Recombinant Human Arginase 1 in Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT02899286
Bio-Cancer Treatment International Limited
Acute Myeloid Leukemia
Start: 2016-09-30
End: 2020-03-31
Target: 25
Updated: 2017-07-28
Related Papers
Abstract NG07: Targeting polyamines metabolism in acute myeloid leukemia stem cells
Cancer Research
2023-04-04
Metabolic therapy with PEG-arginase induces a sustained complete remission in immunotherapy-resistant melanoma.
2018-05-18
47 citations